byiShook Opinion
Sep 23, 2024 - 13:05
Biohaven stock jumped Monday after the company's experimental drug slowed progression in a rare disease with no approved treatments. The post Biohaven Surges After Delaying Progression By Up To 70% In A Rare Disease appeared first on Investor's Business Daily.
Biohaven stock jumped Monday after the company's experimental drug slowed progression in a rare disease with no approved treatments.
The post Biohaven Surges After Delaying Progression By Up To 70% In A Rare Disease appeared first on Investor's Business Daily.